These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

877 related articles for article (PubMed ID: 33545796)

  • 1. The features comparison between patients in the ICU and general wards and between patients with different outcomes: a 2020 COVID-19 study.
    Chen Y; Geng Y; Xu X; Chen X; Gao J; Li J; Zhang X
    Ann Palliat Med; 2021 Jan; 10(1):672-680. PubMed ID: 33545796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meta-analysis investigating the relationship between clinical features, outcomes, and severity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia.
    Li J; He X; Yuan Yuan ; Zhang W; Li X; Zhang Y; Li S; Guan C; Gao Z; Dong G
    Am J Infect Control; 2021 Jan; 49(1):82-89. PubMed ID: 32540370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laboratory features of severe vs. non-severe COVID-19 patients in Asian populations: a systematic review and meta-analysis.
    Ghahramani S; Tabrizi R; Lankarani KB; Kashani SMA; Rezaei S; Zeidi N; Akbari M; Heydari ST; Akbari H; Nowrouzi-Sohrabi P; Ahmadizar F
    Eur J Med Res; 2020 Aug; 25(1):30. PubMed ID: 32746929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of risk factors for in-hospital death of COVID - 19 pneumonia -- lessions from the early outbreak.
    Wang Z; Wang Z
    BMC Infect Dis; 2021 Jan; 21(1):113. PubMed ID: 33494706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive role of clinical features in patients with coronavirus disease 2019 for severe disease.
    Mo J; Liu J; Wu S; LÜ A; Xiao L; Chen D; Zhou Y; Liang L; Liu X; Zhao J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 May; 45(5):536-541. PubMed ID: 32879103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiological, clinical, and laboratory findings for patients of different age groups with confirmed coronavirus disease 2019 (COVID-19) in a hospital in Saudi Arabia.
    Ibrahim ME; Al-Aklobi OS; Abomughaid MM; Al-Ghamdi MA
    PLoS One; 2021; 16(4):e0250955. PubMed ID: 33914805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laboratory predictors of death from coronavirus disease 2019 (COVID-19) in the area of Valcamonica, Italy.
    Bonetti G; Manelli F; Patroni A; Bettinardi A; Borrelli G; Fiordalisi G; Marino A; Menolfi A; Saggini S; Volpi R; Anesi A; Lippi G
    Clin Chem Lab Med; 2020 Jun; 58(7):1100-1105. PubMed ID: 32573995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics of 71 patients with coronavirus disease 2019.
    Xiao M; Hou M; Liu X; Li Z; Zhao Q
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Jul; 45(7):790-796. PubMed ID: 32879082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Characteristics and Immune Responses of 137 Deceased Patients With COVID-19: A Retrospective Study.
    Cui N; Yan R; Qin C; Zhao J
    Front Cell Infect Microbiol; 2020; 10():595333. PubMed ID: 33365277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics and risk factors for severity of COVID-19 outside Wuhan: a double-center retrospective cohort study of 213 cases in Hunan, China.
    Hu X; Hu C; Yang Y; Chen J; Zhong P; Wen Y; Chen X
    Ther Adv Respir Dis; 2020; 14():1753466620963035. PubMed ID: 33138694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and Immune Features of Hospitalized Pediatric Patients With Coronavirus Disease 2019 (COVID-19) in Wuhan, China.
    Wu H; Zhu H; Yuan C; Yao C; Luo W; Shen X; Wang J; Shao J; Xiang Y
    JAMA Netw Open; 2020 Jun; 3(6):e2010895. PubMed ID: 32492165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishing a model for predicting the outcome of COVID-19 based on combination of laboratory tests.
    Wang F; Hou H; Wang T; Luo Y; Tang G; Wu S; Zhou H; Sun Z
    Travel Med Infect Dis; 2020; 36():101782. PubMed ID: 32526372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokine storm in severe COVID-19 pneumonia.
    Gürsoy B; Sürmeli CD; Alkan M; Satıcı C; Altunok ES; Kamat S; Demirok B; Demirkol MA; Börü A
    J Med Virol; 2021 Sep; 93(9):5474-5480. PubMed ID: 33963559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temporal changes in laboratory markers of survivors and non-survivors of adult inpatients with COVID-19.
    Ouyang SM; Zhu HQ; Xie YN; Zou ZS; Zuo HM; Rao YW; Liu XY; Zhong B; Chen X
    BMC Infect Dis; 2020 Dec; 20(1):952. PubMed ID: 33308159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of the Relationship between Mortality and Troponin I Levels in Hospitalized Patients with the Novel Coronavirus (COVID-19).
    Özyılmaz S; Ergün Alış E; Ermiş E; Allahverdiyev S; Uçar H
    Medicina (Kaunas); 2020 Dec; 56(12):. PubMed ID: 33322097
    [No Abstract]   [Full Text] [Related]  

  • 16. Routine laboratory parameters in estimating mortality and morbidity in COVID-19 diagnosed cases followed in the intensive care unit.
    Kutlusoy S; Koca E
    Eur Rev Med Pharmacol Sci; 2023 Jun; 27(12):5885-5892. PubMed ID: 37401326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CLINICAL CHARACTERISTICS OF 28 PATIENTS WITH DIABETES AND COVID-19 IN WUHAN, CHINA.
    Wang F; Yang Y; Dong K; Yan Y; Zhang S; Ren H; Yu X; Shi X
    Endocr Pract; 2020 Jun; 26(6):668-674. PubMed ID: 32357072
    [No Abstract]   [Full Text] [Related]  

  • 18. Risk factors for secondary hemophagocytic lymphohistiocytosis in severe coronavirus disease 2019 adult patients.
    Meng M; Chen L; Zhang S; Dong X; Li W; Li R; Deng Y; Wang T; Xu Y; Liu J; Huang Y; Chen Y; Huang S; Wen Z; Zhang L; Du H; Liu Y; Annane D; Qu J; Chen D
    BMC Infect Dis; 2021 Apr; 21(1):398. PubMed ID: 33926377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiological characteristics and clinical features of 32 critical and 67 noncritical cases of COVID-19 in Chengdu.
    Zheng Y; Xu H; Yang M; Zeng Y; Chen H; Liu R; Li Q; Zhang N; Wang D
    J Clin Virol; 2020 Jun; 127():104366. PubMed ID: 32302954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated glucose level leads to rapid COVID-19 progression and high fatality.
    Wang W; Shen M; Tao Y; Fairley CK; Zhong Q; Li Z; Chen H; Ong JJ; Zhang D; Zhang K; Xing N; Guo H; Qin E; Guan X; Yang F; Zhang S; Zhang L; He K
    BMC Pulm Med; 2021 Feb; 21(1):64. PubMed ID: 33627118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.